Fairvalue-Calculator Fairvalue-Calculator
EN DE

Photoelectron Corporation (PECN) Fair Value & Analysis

Healthcare · US · Market cap $20.1M

Price$1.02
Fair Value$0.1800
Upside-82.3%
Quality85/100
Evidence: Low Range $0.1300 – $0.2200

Fair value as of: Jun 23, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Photoelectron Corporation (PECN) currently trades at $1.02, while our model-based Fair Value estimate is $0.1800 — implying the stock looks roughly 82.3% overvalued today. We read business quality at 85/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Photoelectron Corporation, a technology company, engages in the development, manufacture, and marketing of miniature x-ray systems for multiple market applications. It creates and adapts miniature x-ray systems for various applications in healthcare and nonhealthcare related markets. The company offers micro-adaptive x-ray systems designed for x-ray fluorescence analysis, intravascular radiation therapy, brachytherapy, radiosurgery, intraoperative radiation therapy, and instrumentation to the industrial and medical markets through original equipment manufacturers. Photoelectron Corporation was founded in 1989 and is based in North Billerica, Massachusetts.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Photoelectron Corporation (PECN) undervalued?
As of Jun 23, 2026, our model estimates a fair value of $0.1800 versus a price of $1.02 — about −82% (overvalued). Model-based estimate, not financial advice.
What is the fair value of PECN?
Our 21-model fair value for Photoelectron Corporation is $0.1800 (as of Jun 23, 2026), built from audited fundamentals. The current price is $1.02.
What is the quality score of PECN?
Photoelectron Corporation has a Quality Score of 85/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.